Journament

Keyword Connections - heparin Keywords

Connection Type	Connection
Journals	Carbohydrate polymers Journal of thrombosis and haemostasis : JTH nmc case report journal
Research Groups	No Research Group Connected
Bibliographies	[1] Evaluation of functional assays for the diagnosis of heparin induced thrombocytopenia using 5B9, a monoclonal IgG that mimics human antibodies. [2] Coil Embolization for a Cerebral Aneurysm in a Heart Transplantation Patient: A Case Report. [3] The Antitumor Effect of Heparin is not Mediated by Direct NK Cell Activation [4] The "warfarin window" in pregnancy: the importance of half-life. [5] comparison of two doses of heparin on outcome in off-pump coronary artery bypass surgery patients: a prospective randomized control study [6] primary percutaneous transluminal coronary angioplasty in the acute infarction of the right ventricle [7] variability in the clinical practice of maintaining the patency of peripheral intravenous catheters variabilidad en la práctica clínica del mantenimiento de la permeabilidad de catéteres venosos periféricos [8] the investigation effect of heparin infusion on plasma glucose and lactate during submaximal exercise [9] use of heparin and the related incidence of heparininduced thrombocytopenia in an education and research hospital in turkey [10] the utility of onion extract gel containing topical allantoin and heparin after surgical treatment of upper extremity burn scars [11] structure-activity relationships of bioengineered heparin/heparan sulfates produced in different bioreactors [12] heparin/heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use [13] effect of heparin in combined with magnesium sulfate on the blood gas and blood viscosity in patients with pulmonary heart failure [14] modular synthesis of heparin-related tetra-, hexa- and octasaccharides with differential o-6 protections: programming for regiodefined 6-o-modifications [15] [The present treatment of acute renal insufficiency]. [16] Lipoprotein-lipase responses to heparin [17] Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [18] Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [19] Current structural biology of the heparin interactome. [20] Anti-inflammatory surface coatings based on polyelectrolyte multilayers of heparin and polycationic nanoparticles of naproxen-bearing polymeric drugs. [21] Cutaneous delayed-type allergic reaction to heparins. Review of the literature from a clinical case [22] The preparation and morphology control of heparin-based pH sensitive polyion complexes and their application as drug carriers. [23] Water-soluble Glucosamine-coated AIE-Active Organic Nanoparticles: Design, Synthesis and Assembly for Specific Detection of Heparin Based on Carbohydrate-carbohydrate Interactions. [24] Dramatic improvement in traumatic hyphema with heparin eye drops [25] Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction. [26] A magnetically modified black phosphorus nanosheet-based heparin delivery platform for preventing DVT accurately. [27] Evaluation of functional assays for the diagnosis of heparin induced thrombocytopenia using 5B9, a monoclonal IgG that mimics human antibodies. [28] The versatile heparin in COVID-19. [29] The Antitumor Effect of Heparin is not Mediated by Direct NK Cell Activation [30] comparison of two doses of heparin on outcome in off-pump coronary artery bypass surgery patients: a prospective randomized control study [31] rivaroxaban versus low weight heparins for venous thromboembolism prophylaxis after major hip and knee arthroplasty: systematic review and metaanalysis = rivaroxaban frente a heparinas de bajo peso molecular para la prevención de la tromboembolia venosa posterior al reemplazo total de cadera o rodilla: revisión sistemática de la literatura y metaanálisisis [32] in vitro and in vivo biocompatibility evaluation of polyallylamine and macromolecular heparin conjugates modified alginate microbeads [33] endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor [34] evaluation of the efficacy of combined therapy of patients with diabetic foot syndrome using Αlpha-lipoic acid preparations and low-molecular-weight heparin [35] low-molecular-weight heparin reduces ventilation-induced lung injury through hypoxia inducible factor-1α in a murine endotoxemia model [36] the investigation effect of heparin infusion on plasma glucose and lactate during submaximal exercise [37] heparina e k3edta como anticoagulantes para tambaqui (colossoma macropomum cuvier, 1816) heparin and k3edta as anticoagulants for tambaqui (colossoma macropomum cuvier, 1816) [38] use of heparin and the related incidence of heparininduced thrombocytopenia in an education and research hospital in turkey [39] the utility of onion extract gel containing topical allantoin and heparin after surgical treatment of upper extremity burn scars [40] structure-activity relationships of bioengineered heparin/heparan sulfates produced in different bioreactors [41] heparin/heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use [42] novel stable cytokine delivery system in physiological ph solution: chitosan oligosaccharide/heparin nanoparticles [43] coexistence of antiphospholipid syndrome and heparin-induced thrombocytopenia in a patient with recurrent venous thromboembolism [44] hematoma espontáneo de gran tamaño en la pared torácica en un paciente en tratamiento con antiagregantes plaquetarios y heparina de bajo peso molecular. necesidad de tratamiento quirúrgico urgente [45] effect of heparin in combined with magnesium sulfate on the blood gas and blood viscosity in patients with pulmonary heart failure [46] administration of low molecular weight and unfractionated heparin during percutaneous coronary intervention [47] heparin-enhanced harvest and decanting for autologous fat transfer [48] preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis [49] the radiation protection role of heparin-sod conjugate in irradiated mice [50] modular synthesis of heparin-related tetra-, hexa- and octasaccharides with differential o-6 protections: programming for regiodefined 6-o-modifications [51] heparin-based nanoparticles: an overview of their applications [52] incorporation of heparin-binding proteins into preformed dextran sulfate-chitosan nanoparticles [53] Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study [54] Lipoprotein-lipase responses to heparin [55] Lipoprotein-lipase responses to heparin [56] Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial [57] Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial [58] Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study - Annals of Intensive Care [59] Heparin-Free Prolonged Intermittent Hemodialysis Using Calcium-Free Citrate Dialysate in Critically Ill Patients [60] Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.